Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Strong Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

A2Z Smart Technologies Corp. Common Shares (AZ)

https://www.a2zas.com

A2Z Smart Technologies Corp is a technology company in Israel providing products to the Israeli Defense and Security Forces, specializing in military unmanned robotics and state-of-the-art automation and electronics technology. The company commenced the development of two products for the automotive market. The first product is a capsule that can be placed in a fuel tank to prevent gas tank explosions. The second product under development is a vehicle cover device that will protect automobiles from extreme weather conditions while the vehicle is not in use. The company also provides maintenance services to both external and in-house complex electronic systems and products.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/01/2020

Market Cap

30,653,143

Shares Outstanding

41,210,000

Weighted SO

41,205,742

Total Employees

N/A

Upcoming Earnings

N/A

Beta

2.1490

Last Div

0.0000

Range

0.34-2.5

Chg

0.0239

Avg Vol

134374

Mkt Cap

30653143

Exch

NASDAQ

Country

CA

Phone

N/A

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

4.2749

EV Multiple

-1.7785

P/FV

8.1925

Div Yield %

0.0000

P/E

-4.7964

PEG

-0.1504

Payout

0.0000

Current Ratio

0.5262

Quick Ratio

0.4905

Cash Ratio

0.1076

DSO

131.9202

DIO

13.2887

Op Cycle

145.2089

DPO

156.5974

CCC

-11.3885

Gross Margin

0.0770

Op Margin

-2.3211

Pretax Margin

-1.4609

Net Margin

-1.1189

Eff Tax Rate

0.4597

ROA

-1.1116

ROE

-2.4423

ROCE

-36.9097

NI/EBT

0.7659

EBT/EBIT

0.6294

EBIT/Rev

-2.3211

Debt Ratio

0.2394

D/E

0.3678

LT Debt/Cap

0.0275

Total Debt/Cap

0.2689

Int Coverage

-118.8980

CF/Debt

-7.6628

Equity Multi

1.5366

Rec Turnover

2.7668

Pay Turnover

2.3308

Inv Turnover

27.4670

FA Turnover

3.9931

Asset Turnover

0.9934

OCF/Share

-0.2559

FCF/Share

-0.2569

Cash/Share

0.0141

OCF/Sales

-1.8463

FCF/OCF

1.0038

CF Coverage

-7.6628

ST Coverage

-8.3017

CapEx Coverage

-263.9277

Div&CapEx Cov

-263.9277

P/BV

8.1925

P/B

8.1925

P/S

4.2749

P/E

-4.7964

P/FCF

-2.3066

P/OCF

-2.9067

P/CF

-2.9067

PEG

-0.1504

P/S

4.2749

EV Multiple

-1.7785

P/FV

8.1925

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 26, 14:58 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LAZR GlobeNewswire Inc. Jul 16, 04:30 [Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire Inc. Jun 27, 23:13 TEM Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Securities Fraud Class Action Against TEM The Motley Fool May 30, 21:15 If There's Such a Thing as a Recession-Resistant Stock, This Is It The Motley Fool May 10, 23:32 Berkshire Hathaway Is a Great Bear Market Stock. These 2 Are Even Better Buys. GlobeNewswire Inc. May 08, 22:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – PLYA, AZEK, TURN, ICAD The Motley Fool Apr 19, 18:14 2 Stocks Crushing It With Share Buybacks GlobeNewswire Inc. Mar 29, 16:32 SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding GlobeNewswire Inc. Mar 10, 00:30 Global Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc. GlobeNewswire Inc. Feb 15, 22:50 AZN IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN The Motley Fool Feb 15, 13:45 2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 GlobeNewswire Inc. Feb 09, 16:14 ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN GlobeNewswire Inc. Jan 30, 23:52 ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN GlobeNewswire Inc. Jan 30, 02:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, IIPR, Block, and Crocs and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 22, 02:04 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN GlobeNewswire Inc. Jan 18, 14:21 ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN GlobeNewswire Inc. Jan 13, 23:55 AstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses. February 21, 2025 Deadline to file Lead Plaintiff Motion GlobeNewswire Inc. Jan 13, 03:17 ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN GlobeNewswire Inc. Jan 12, 21:00 AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire Inc. Jan 09, 23:30 ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

Revenue Product Segmentation